Literature DB >> 7779439

Protection against inhalation toxicity of ricin and abrin by immunisation.

G D Griffiths1, C D Lindsay, A C Allenby, S C Bailey, J W Scawin, P Rice, D G Upshall.   

Abstract

1. Abrin and ricin are highly toxic plant proteins which are very similar in structure and function and inhibit protein synthesis in eukaryotes. 2. Rats have been immunised against either toxin using formaldehyde-toxoids by three subcutaneous injections at intervals of 3 weeks. For abrin, serum titres in 14 out of 15 rats were raised to between 1:12800 and 1:51200 after two injections, 6 weeks from the start of the experiment. Titres of between 1:256 and 1:1024 were also measured in lung washes after challenge with active abrin toxin. 3. The three major antibody classes, IgG, IgM and IgA were present in the immune sera but IgG and IgA only were detected in lung washes. The proportion of IgA to IgG was higher in the lung fluid than in sera. Rats immunised by abrin toxoid were protected against 5 LCt50's of abrin by inhalation but others exposed to ricin were not. 4. For ricin, serum titres ranged from 1:800 to 1:25600 after two injections and after a third injection the titre range was the same but population samples were weighted towards the higher titres. All rats immunised with ricin toxoid survived the challenge of 5 LCt50's of ricin toxin by inhalation over the observation period of 28 days post-challenge. 5. Representative immunised rats (abrin toxoid) were taken at various times post-exposure, humanely killed and tissues were examined for pathological changes. It was concluded that an apparently severe lung lesion occurred at a later time than in non-immunised, toxin challenged rats. This damage was not lethal over the experimental observation periods. 6. Immunisation by the sub-cutaneous route therefore protects against lethality from challenge by inhalation of ricin or abrin toxins but does not prevent significant lung damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779439     DOI: 10.1177/096032719501400201

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  16 in total

1.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

2.  Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin.

Authors:  Yuwei Zhu; Jianxin Dai; Tiancheng Zhang; Xu Li; Pengfei Fang; Huajing Wang; Yongliang Jiang; Xiaojie Yu; Tian Xia; Liwen Niu; Yajun Guo; Maikun Teng
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

3.  A recombinant chimeric protein containing B chains of ricin and abrin is an effective vaccine candidate.

Authors:  Junhong Wang; Shan Gao; Tao Zhang; Lin Kang; Wuchun Cao; Na Xu; Wensen Liu; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014-02-07       Impact factor: 3.452

Review 4.  Immunity to ricin: fundamental insights into toxin-antibody interactions.

Authors:  Joanne M O'Hara; Anastasiya Yermakova; Nicholas J Mantis
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Ricin Toxicity: Clinical and Molecular Aspects.

Authors:  Mohammad Moshiri; Fatemeh Hamid; Leila Etemad
Journal:  Rep Biochem Mol Biol       Date:  2016-04

6.  Ribosome depurination is not sufficient for ricin-mediated cell death in Saccharomyces cerevisiae.

Authors:  Xiao-Ping Li; Marianne Baricevic; Hemalatha Saidasan; Nilgun E Tumer
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

7.  Truncated abrin A chain expressed in Escherichia coli: a promising vaccine candidate.

Authors:  Tao Zhang; Lin Kang; Shan Gao; Hao Yang; Wenwen Xin; Junhong Wang; Maowen Guo; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

8.  Intrapulmonary delivery of ricin at high dosage triggers a systemic inflammatory response and glomerular damage.

Authors:  John Wong; Veselina Korcheva; David B Jacoby; Bruce Magun
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

9.  A pilot clinical trial of a recombinant ricin vaccine in normal humans.

Authors:  Ellen S Vitetta; Joan E Smallshaw; Elaine Coleman; Hasan Jafri; Callie Foster; Robert Munford; John Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

Review 10.  AB toxins: a paradigm switch from deadly to desirable.

Authors:  Oludare Odumosu; Dequina Nicholas; Hiroshi Yano; William Langridge
Journal:  Toxins (Basel)       Date:  2010-06-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.